Mari Nordbo Gynnild
AHL-senteret, Øya, Prinsesse Kristinas gt 3
Om
Utdanning
Cand.med. NTNU 2013. Turnustjeneste ved St. Olavs Hospital og Røros Legesenter, 2014-2015. Lege i spesialisering generell indremedisin Sykehuset Levanger 2015 - 2017. Stipendiat ved NTNU 2017-2021. Disputerte med avhandlingen "Residual cardiovascular risk after ischemic stroke - Risk factors, medication adherence and risk-benefit considerations" i mars 2022. Lege i spesialisering Klinikk for hjertemedisin / Medisinsk klinikk, St. Olavs Hospital 2021 -.
Forskningsinteresser
Forebygging av hjerte- og karsykdommer, kardiovaskulær farmakologi, kardiovaskulær risikoprediksjon og kardioonkologi. Skrev doktorgrad om etterlevelse for medikamentell sekundærforebygging og prediksjon av framtidig kardiovaskulær risiko. Jobber nå primært med forebygging av hjertekomplikasjoner ved kreftbehandling (PRADA II-studien) og ekstern validering av kardiovaskulære risikoprediksjonsmodeller.
Forskning
PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial
A randomized, placebo-controlled, multicenter trial assessing if sacubitril/valsartan given concomitantly with early breast cancer treatment regimens including anthracyclines, with or without trastuzumab, may prevent cardiac dysfunction.
Risk prediction for individualized cardiovascular disease prevention
This project aims to externally validate and compare guideline-recommended cardiovascular risk prediction tools, as well as tailor models to local settings, new settings and investigate whether these models can be extended by addition of new predictors.
Publikasjoner
2024
-
Gynnild, Mari Nordbø.
(2024)
Kardiovaskulær risikostratifisering.
Hjerteforum
Leserinnlegg
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven HJ;
Vinje, Victoria;
Dorresteijn, Jannick AN;
Visseren, Frank.
(2024)
External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment.
European Heart Journal, Supplement
Sammendrag/abstract
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven HJ;
Vinje, Victoria;
Dorresteijn, Jannick AN;
Visseren, Frank.
(2024)
External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients.
European Heart Journal, Supplement
Sammendrag/abstract
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Munkhaugen, John;
Dalen, Håvard;
Ueda, Peter;
Jernberg, Thomas.
(2024)
Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model.
European Heart Journal, Supplement
Sammendrag/abstract
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Munkhaugen, John;
Dalen, Håvard;
Lim, Carl-Emil;
Ueda, Peter.
(2024)
Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model.
European Heart Journal, Supplement
Sammendrag/abstract
2023
-
Aakerøy, Rachel;
Gynnild, Mari Nordbø;
Løfblad, Lena;
Dyrkorn, Roar;
Ellekjær, Hanne;
Lydersen, Stian.
(2023)
Direct oral anticoagulant concentrations and adherence in stroke patients.
Basic & Clinical Pharmacology & Toxicology
Vitenskapelig artikkel
2022
-
Hageman, Steven HJ;
McKay, Ailsa;
Ueda, Peter;
Gunn, Laura;
Jernberg, Tomas;
Hagström, Emil.
(2022)
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm.
European Heart Journal
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø.
(2022)
Residual cardiovascular risk after ischemic stroke. Risk factors, medication adherence and risk-benefit considerations. .
Doctoral theses at NTNU (2022:87)
Doktorgradsavhandling
-
Gynnild, Mari Nordbø;
Hageman, Steven H. J.;
Spigset, Olav;
Lydersen, Stian;
Saltvedt, Ingvild;
Dorresteijn, Jannick AN.
(2022)
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment.
Open heart
Vitenskapelig artikkel
2021
-
Gynnild, Mari Nordbø;
Hageman, Steven HJ;
Dorresteijn, Jannick AN;
Spigset, Olav;
Lydersen, Stian;
Wethal, Torgeir.
(2021)
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention.
Clinical Epidemiology
Vitenskapelig artikkel
-
Aam, Stina;
Gynnild, Mari Nordbø;
Munthe-Kaas, Ragnhild;
Saltvedt, Ingvild;
Lydersen, Stian;
Knapskog, Anne Brita.
(2021)
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study.
Frontiers in Neurology
Vitenskapelig artikkel
2020
-
Gynnild, Mari Nordbø;
Aakerøy, Rachel;
Spigset, Olav;
Askim, Torunn;
Beyer, Mona Kristiansen;
Ihle-Hansen, Hege.
(2020)
Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.
Journal of Internal Medicine
Vitenskapelig artikkel
2015
-
Anshushaug, Malin;
Gynnild, Mari Aas;
Kaasa, Stein;
Kvikstad, Anne;
Grønberg, Bjørn H..
(2015)
Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Acta Oncologica
Vitenskapelig artikkel
Tidsskriftspublikasjoner
-
Gynnild, Mari Nordbø.
(2024)
Kardiovaskulær risikostratifisering.
Hjerteforum
Leserinnlegg
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven HJ;
Vinje, Victoria;
Dorresteijn, Jannick AN;
Visseren, Frank.
(2024)
External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment.
European Heart Journal, Supplement
Sammendrag/abstract
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven HJ;
Vinje, Victoria;
Dorresteijn, Jannick AN;
Visseren, Frank.
(2024)
External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients.
European Heart Journal, Supplement
Sammendrag/abstract
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Munkhaugen, John;
Dalen, Håvard;
Ueda, Peter;
Jernberg, Thomas.
(2024)
Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model.
European Heart Journal, Supplement
Sammendrag/abstract
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Munkhaugen, John;
Dalen, Håvard;
Lim, Carl-Emil;
Ueda, Peter.
(2024)
Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model.
European Heart Journal, Supplement
Sammendrag/abstract
-
Aakerøy, Rachel;
Gynnild, Mari Nordbø;
Løfblad, Lena;
Dyrkorn, Roar;
Ellekjær, Hanne;
Lydersen, Stian.
(2023)
Direct oral anticoagulant concentrations and adherence in stroke patients.
Basic & Clinical Pharmacology & Toxicology
Vitenskapelig artikkel
-
Hageman, Steven HJ;
McKay, Ailsa;
Ueda, Peter;
Gunn, Laura;
Jernberg, Tomas;
Hagström, Emil.
(2022)
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm.
European Heart Journal
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Hageman, Steven H. J.;
Spigset, Olav;
Lydersen, Stian;
Saltvedt, Ingvild;
Dorresteijn, Jannick AN.
(2022)
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment.
Open heart
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Hageman, Steven HJ;
Dorresteijn, Jannick AN;
Spigset, Olav;
Lydersen, Stian;
Wethal, Torgeir.
(2021)
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention.
Clinical Epidemiology
Vitenskapelig artikkel
-
Aam, Stina;
Gynnild, Mari Nordbø;
Munthe-Kaas, Ragnhild;
Saltvedt, Ingvild;
Lydersen, Stian;
Knapskog, Anne Brita.
(2021)
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study.
Frontiers in Neurology
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Aakerøy, Rachel;
Spigset, Olav;
Askim, Torunn;
Beyer, Mona Kristiansen;
Ihle-Hansen, Hege.
(2020)
Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.
Journal of Internal Medicine
Vitenskapelig artikkel
-
Anshushaug, Malin;
Gynnild, Mari Aas;
Kaasa, Stein;
Kvikstad, Anne;
Grønberg, Bjørn H..
(2015)
Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Acta Oncologica
Vitenskapelig artikkel
Rapport
-
Gynnild, Mari Nordbø.
(2022)
Residual cardiovascular risk after ischemic stroke. Risk factors, medication adherence and risk-benefit considerations. .
Doctoral theses at NTNU (2022:87)
Doktorgradsavhandling
Undervisning
Veiledning
Formidling
2024
-
Vitenskapelig foredragHoltrop, Joris; Gynnild, Mari Nordbø; Ueda, Peter; Tuñón, José; Bhat, Deepak; Jernberg, Thomas. (2024) Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. European Society of Cardiology ESC Congress London , London 2024-08-29 - 2024-09-02
-
Vitenskapelig foredragGynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven; Vinje, Victoria; Dorresteijn, Jannick; Visseren, Frank. (2024) External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients . European Society of Cardiology ESC Congress London , London 2024-08-29 - 2024-09-02
-
Vitenskapelig foredragGynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven; Vinje, Victoria; Dorresteijn, Jannick A.N.; Visseren, Frank. (2024) External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment . European Society of Cardiology ESC Congress London , London 2024-08-29 - 2024-09-02
2022
-
Faglig foredragGynnild, Mari Nordbø. (2022) Etterlevelse av forbyggende behandling, er vi sammen gode nok? . Norsk forening for geriatri Geriatrikongressen 2022-04-04 - 2022-04-05
-
IntervjuGynnild, Mari Nordbø. (2022) Under halvparten nådde de anbefalte målene for blodtrykk og kolesterol. Dagens Medisin Dagens Medisin [Avis] 2022-05-18
2021
-
Faglig foredragGynnild, Mari Nordbø. (2021) Optimalisert etterlevelse for sekundærprofylaktiske legemidler. Norsk hjerneslagforening Bergenskonferansen, Norsk hjerneslagforening , Bergen 2021-10-20 - 2021-10-21
2020
-
PosterGynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Ellekjær, Hanne. (2020) Adherence to secondary preventive anticoagulation and risk for subsequent stroke and death. European Stroke Organisation and World Stroke Organization European Stroke Organisation and World Stroke Organization (ESO-WSO 2020) Virtual Conference , Wien 2020-11-07 - 2020-11-09
2018
-
PosterGynnild, Mari Nordbø; Ellekjær, Hanne. (2018) Adherence to secondary prevention after stroke. European Stroke Organisation European Stroke Organisation Conference (ESOC) , Göteborg, Sweden 2018-05-16 - 2018-05-18